MorphImmune – Could Cellular Reprogramming Be the Next Innovation in Cancer and Fibrosis?
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune's proprietary platform that enables reprogramming or removal of aberrant cells wi...
5262 articles
Ronald Martell, President and CEO at MorphImmune discusses MorphImmune's proprietary platform that enables reprogramming or removal of aberrant cells wi...
Angela Stoehr, OB/GYN, addresses how the pandemic exacerbated the opioid epidemic and the need to refocus on non-opioid pain management approaches after...
Sham Dholakia, MD, Chief Medical Officer at CareDx, a company focused on high-value healthcare solutions for transplant patients, discusses the Assessin...
Amir Mansouri, PhD, CEO and Co-Founder of SprintRay, discusses how his vision to revolutionize the dental industry with new “on-demand” 3D printing ...
Samuel Kim, a thoracic surgeon at Northwestern Medicine discusses the Ambulatory Precision Lung Sparing (A-PLUS) surgery program born from the need to b...
Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, inclu...
Brian Koffman, Executive Vice President and Chief Medical Officer, CLL (chronic lymphocytic leukemia) Society and a CLL patient discusses the impact and...
Larry Edwards, Professor of Medicine, Division of Rheumatology and Clinical Immunology, and Program Director and Vice Chairman of the Department of Medi...
Waqaas Al-Siddiq, founder and CEO of Biotricity, is a young entrepreneur who founded Biotricity after working in technology and finance and has a backgr...
Alison Darcy, President and Founder of Woebot Health discusses key findings of their survey "A Paradigm Shift: Consumer Attitudes Toward Mental Health T...